Bristol Myers Squibb Evolves and Expands Standing in the Gaap to Advance More Equitable Care in Multiple Myeloma as Program Marks Ten Years
Go back to Bristol Myers Squibb Evolves and Expands Standing in the Gaap to Advance More Equitable Care in Multiple Myeloma as Program Marks Ten Years| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 57.13 +0.23 (0.40%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $56.90 | 52 Week High | $77.12 | |||
| Open | $57.45 | 52 Week Low | $49.03 | |||
| Day High | $57.60 | P/E | 37.10 | |||
| Day Low | $56.77 | EPS | $1.54 | |||
| Volume | 7,839,148 | |||||
